BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14532998)

  • 1. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
    Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.
    Ryu HS; Chang KH; Yang HW; Kim MS; Kwon HC; Oh KS
    Gynecol Oncol; 2000 Mar; 76(3):320-5. PubMed ID: 10684704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
    Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
    Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
    Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
    Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.
    Okamoto E; Sumi T; Misugi F; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Jan; 15(1):41-7. PubMed ID: 15583826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Chen H; Liang C; Zhang L; Huang S; Wu X
    Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
    Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Am J Clin Pathol; 2001 Nov; 116(5):729-37. PubMed ID: 11710691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
    Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.
    Manchana T; Triratanachat S; Sirisabya N; Vasuratna A; Termrungruanglert W; Tresukosol D
    Gynecol Oncol; 2006 Mar; 100(3):556-60. PubMed ID: 16246405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
    Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.
    Farley J; Uyehara C; Hashiro G; Belnap C; Birrer M; Salminen E
    Gynecol Oncol; 2004 Feb; 92(2):596-602. PubMed ID: 14766253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy.
    Faried LS; Faried A; Kanuma T; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
    Oncol Rep; 2006 Jul; 16(1):57-63. PubMed ID: 16786123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Zannoni GF; Legge F; Gessi M; Salutari V; Scambia G
    Oncol Rep; 2003; 10(6):1799-804. PubMed ID: 14534699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.
    Ishikawa H; Ohno T; Kato S; Wakatsuki M; Iwakawa M; Ohta T; Imai T; Mitsuhashi N; Noda SE; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1347-55. PubMed ID: 16979845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.